Toyoda H - Search Results

1

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.

Hasegawa M, Nishigaki N, Washio Y, Kano K, Harris PA, Sato H, Mori I, West RI, Shibahara M, Toyoda H, Wang L, Nolte RT, Veal JM, Cheung M. Hasegawa M, et al. Among authors: toyoda h. J Med Chem. 2007 Sep 6;50(18):4453-70. doi: 10.1021/jm0611051. Epub 2007 Aug 4. J Med Chem. 2007. PMID: 17676829

2

Dual enzyme-linked immunosorbent assay system for detection of endogenous kinase activities of mitogen- and stress-activated protein kinase-1/2.

Ishii T, Sootome H, Toyoda H, Suda M, Noumi T, Yamashita K. Ishii T, et al. Among authors: toyoda h. Assay Drug Dev Technol. 2007 Aug;5(4):523-33. doi: 10.1089/adt.2007.063. Assay Drug Dev Technol. 2007. PMID: 17767420

3

Anti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time.

Motoi S, Toyoda H, Obara T, Ohta E, Arita Y, Negishi K, Moriya K, Kuboi Y, Soejima M, Imai T, Ido A, Tsubouchi H, Kawano T. Motoi S, et al. Among authors: toyoda h. Int J Mol Sci. 2019 Apr 12;20(8):1821. doi: 10.3390/ijms20081821. Int J Mol Sci. 2019. PMID: 31013780 Free PMC article.

4

Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.

Sakane S, Hikita H, Shirai K, Sakamoto T, Narumi R, Adachi J, Kakita N, Yamada Y, Toyoda H, Takahashi H, Suda G, Kai M, Tahata Y, Sakamori R, Kumazaki S, Fukumoto K, Myojin Y, Murai K, Kodama T, Tatsumi T, Tomonaga T, Sakamoto N, Morii E, Takehara T. Sakane S, et al. Among authors: toyoda h. Hepatol Commun. 2024 Jun 3;8(6):e0448. doi: 10.1097/HC9.0000000000000448. eCollection 2024 Jun 1. Hepatol Commun. 2024. PMID: 38829196 Free PMC article.

5

Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.

Kumazaki S, Hikita H, Tahata Y, Sung JH, Fukumoto K, Myojin Y, Sakane S, Murai K, Sasaki Y, Shirai K, Saito Y, Kodama T, Kakita N, Takahashi H, Toyoda H, Suda G, Morii E, Kojima T, Ebihara T, Shimizu K, Sasaki Y, Tatsumi T, Takehara T. Kumazaki S, et al. Among authors: toyoda h. Aliment Pharmacol Ther. 2024 Jun 3. doi: 10.1111/apt.18063. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38828944

6

Case Report: MYH9-related disease caused by Ala44Pro mutation in a child with a previous diagnosis of chronic immune thrombocytopenia.

Niwa K, Toyoda H, Kohso A, Okumura Y, Kunishima S, Hirayama M. Niwa K, et al. Among authors: toyoda h. Front Pediatr. 2024 May 17;12:1391742. doi: 10.3389/fped.2024.1391742. eCollection 2024. Front Pediatr. 2024. PMID: 38827217 Free PMC article.

7

Efficacy and adverse events of L-Asparaginase administration as a first-line treatment for feline large-cell gastrointestinal lymphoma.

Inazumi H, Toyoda H, Shimano S, Sakuma H, Sakamoto M, Nakagawa T, Fukuoka R, Ohmi A, Chambers JK, Uchida K, Goto-Koshino Y, Tomiyasu H. Inazumi H, et al. Among authors: toyoda h. J Vet Med Sci. 2024 Jun 3. doi: 10.1292/jvms.23-0453. Online ahead of print. J Vet Med Sci. 2024. PMID: 38825481 Free article.

8

Safety evaluation of lenvatinib treatment after atezolizumab plus bevacizumab therapy for patients with unresectable liver cancer: A comparison of lenvatinib as 1st‑ or 2nd‑line treatment.

Kimura M, Yamada S, Go M, Yasuda S, Toyoda H, Usami E. Kimura M, et al. Among authors: toyoda h. Oncol Lett. 2024 May 17;28(1):330. doi: 10.3892/ol.2024.14464. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38807665 Free PMC article.

9

Molecular, Morphological and Electrophysiological Differences between Alpha and Gamma Motoneurons with Special Reference to the Trigeminal Motor Nucleus of Rat.

Kang Y, Saito M, Toyoda H. Kang Y, et al. Among authors: toyoda h. Int J Mol Sci. 2024 May 12;25(10):5266. doi: 10.3390/ijms25105266. Int J Mol Sci. 2024. PMID: 38791305 Free PMC article. Review.

10

Comparison of Efficacy between Pemafibrate and Omega-3-Acid Ethyl Ester in the Liver: the PORTRAIT Study.

Sumida Y, Toyoda H, Yasuda S, Kimoto S, Sakamoto K, Nakade Y, Ito K, Osonoi T, Yoneda M. Sumida Y, et al. Among authors: toyoda h. J Atheroscler Thromb. 2024 May 21. doi: 10.5551/jat.64896. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38777770 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,452 results

Search Page